Castle Biosciences Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC CSTL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

69,628

Value ($000)

2,709

Weight

0.0%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,709	0.0%	69,628	12/31/2025
2025 Q3	11/14/2025	1,308	0.0%	57,460	9/30/2025
2025 Q2	8/14/2025	2,098	0.0%	102,742	6/30/2025
2025 Q1	5/19/2025	1,362	0.0%	68,031	3/31/2025
2024 Q4	2/14/2025	1,759	0.0%	66,018	12/31/2024
2024 Q3	11/14/2024	1,584	0.0%	55,532	9/30/2024
2024 Q2	8/14/2024	1,222	0.0%	56,136	6/30/2024
2024 Q1	5/15/2024	704	0.0%	31,788	3/31/2024
2023 Q4	2/14/2024	588	0.0%	27,261	12/31/2023
2023 Q3	11/13/2023	460	0.0%	27,261	9/30/2023
2023 Q2	8/11/2023	3,574	0.0%	157,322	6/30/2023
2023 Q1	5/15/2023	3,574	0.0%	157,322	3/31/2023
2022 Q4	2/14/2023	3,744	0.0%	159,063	12/31/2022
2022 Q3	11/14/2022	3,817	0.0%	146,346	9/30/2022
2022 Q2	8/12/2022	3,449	0.0%	157,152	6/30/2022
2022 Q1	5/16/2022	7,977	0.0%	177,831	3/31/2022
2021 Q4	2/14/2022	8,027	0.0%	187,243	12/31/2021
2021 Q3	11/15/2021	11,881	0.0%	178,655	9/30/2021
2021 Q2	8/16/2021	13,699	0.0%	186,807	6/30/2021
2021 Q1	5/14/2021	13,252	0.0%	193,578	3/31/2021
2020 Q4	3/1/2021	12,770	0.0%	190,168	12/31/2020
2020 Q3	11/13/2020	13,333	0.0%	259,137	9/30/2020
2020 Q2	8/14/2020	6,184	0.0%	164,079	6/30/2020
2020 Q1	5/15/2020	4,638	0.0%	155,581	3/31/2020